"A phase IIa-IIb placebo-controlled, randomized, clinical trial to assess the efficacy and safety of NASVAC Therapeutic Vaccine Candidate in patients with Chronic Hepatitis B Virus infection"

Trial Profile

"A phase IIa-IIb placebo-controlled, randomized, clinical trial to assess the efficacy and safety of NASVAC Therapeutic Vaccine Candidate in patients with Chronic Hepatitis B Virus infection"

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 06 Sep 2016

At a glance

  • Drugs ABX 203 (Primary) ; ABX 203 (Primary)
  • Indications Hepatitis B
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Feb 2013 Status changed from not yet recruiting to planning as reported by Cuban Clinical Trial Registry.
    • 13 Nov 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top